Instructed late in the day, Peters & Peters successfully defended the president of a global pharmaceuticals group due to stand trial for dishonesty offences. The proceedings were discontinued following lengthy representations made as to the inadequacy of the Crown’s disclosure, following which Peters & Peters obtained a novel and substantial costs award against the Crown.